Mentice reports Q2 2026 EBITDA turnaround to 6.3 million SEK

Mentice reported a significant improvement in Q2 2026 EBITDA, reaching 6.3 million SEK compared to a loss of 8.1 million SEK in the same period last year. The shift indicates a successful scaling of their surgical simulation technology business, though the sustainability of this margin expansion remains to be confirmed in subsequent quarters.